Although the Mdivi-1-mediated inactivation of Drp1 or the decline of Drp1 protein level did not affect the protein expression of RPL22, more experiments such as the knockdown of Drp1 or the nuclear transport prevention approach should be conducted to reveal the Drp1/RPL22 signaling axis in Mdivi-1-challenged gastric cancer cells. This evidence concerns the gene DNM1L and gastric cancer.